Department of Urology, Chang Gung Memorial Hospital-Linkou, 5 Fu-Shing Street, Kweishan, Taoyuan, 333, Taiwan, Republic of China.
School of Medicine, Chang Gung University, 259 Wen-Hwa 1 st Road, Kweishan, Taoyuan, Taiwan, Republic of China.
BMC Geriatr. 2018 Jan 16;18(1):15. doi: 10.1186/s12877-018-0709-3.
To evaluate the long-term surgical outcomes of patients with urinary retention (UR) caused by a benign prostatic obstruction (BPO) who underwent transurethral resection of the prostate (TURP), and compare their outcomes with those of patients who received medication without surgical intervention.
This retrospective cohort study analyzed claims data collected during the period of 1997-2012 from Taiwan's National Health Insurance Research Database. We examined geriatric adverse events among patients who had received a diagnosis of symptomatic benign prostatic hyperplasia and whom experienced UR, and compared those who received TURP and medication only. Primary outcomes included urinary tract infection (UTI), UR, inguinal hernia, hemorrhoids, stroke, acute myocardial infarction, and bony fracture. We excluded patients who had concomitant prostate cancer, bladder cancer, or a long-term urinary catheter indwelling, as well as those who did not receive α-blocker medication regularly. Those aged <50 or >90 years were also excluded. The enrolled patients were categorized into TURP (n = 1218) and medication only (n = 795) groups. After 1:1 propensity score matching, we recorded and compared patients' characteristics, postoperative clinical outcomes, and geriatric adverse events.
The TURP cohort had a lower incidence of UTI and UR during the postoperative follow-up period from 2 months to 3 years than did the medication only group (20.7% vs. 28.9% and 12.5% vs. 27.6%, respectively, p < 0.001). The life-long bone fracture incidence was also lower in the TURP cohort (7.9% vs. 9.2%, p = 0.048). The incidence of other outcomes during the postoperative follow-up period did not differ between the two groups.
Compared with conservative treatment, TURP provides more favorable clinical outcomes in patients with UR caused by BPO. Patients who underwent TURP had a lower risk of UTI, repeat UR episodes, and emergent bony fracture. Thus, early surgical intervention should be considered for such patients.
评估因良性前列腺增生(BPO)导致尿潴留(UR)接受经尿道前列腺切除术(TURP)的患者的长期手术结果,并将其与未接受手术干预的药物治疗患者的结果进行比较。
本回顾性队列研究分析了 1997 年至 2012 年期间从台湾全民健康保险研究数据库收集的理赔数据。我们检查了接受症状性良性前列腺增生诊断并出现 UR 的老年患者的不良事件,并比较了接受 TURP 和仅药物治疗的患者。主要结果包括尿路感染(UTI)、UR、腹股沟疝、痔疮、中风、急性心肌梗死和骨折。我们排除了同时患有前列腺癌、膀胱癌或长期留置导尿管的患者,以及未定期接受α受体阻滞剂治疗的患者。年龄<50 岁或>90 岁的患者也被排除在外。纳入的患者被分为 TURP(n=1218)和仅药物治疗(n=795)组。在 1:1 倾向评分匹配后,我们记录并比较了患者的特征、术后临床结果和老年不良事件。
在术后 2 个月至 3 年的随访期间,TURP 组的 UTI 和 UR 发生率低于仅药物治疗组(分别为 20.7% vs. 28.9%和 12.5% vs. 27.6%,p<0.001)。TURP 组的终身骨折发生率也较低(7.9% vs. 9.2%,p=0.048)。在术后随访期间,两组其他结果的发生率没有差异。
与保守治疗相比,TURP 为 BPO 引起的 UR 患者提供了更有利的临床结果。接受 TURP 的患者发生 UTI、重复 UR 发作和紧急骨折的风险较低。因此,对于此类患者应考虑早期手术干预。